Breast cancer in a transgender man
A
Alison May Berner
(Queen Mary University of London London UK)
T
Tristan Michael MacKenzie
(University of Edinburgh School of Divinity Edinburgh UK)
S
Shirish Kulkarni
(Edinburgh Cancer Center Edinburgh UK)
C
Chin Chong
(Waterside Gender Clinic Edinburgh UK)
L
Loren Schechter
(Gender Affirmation Surgery Rush University Medical Center Chicago Illinois USA)
C
Caroline Michie
(Edinburgh Cancer Center Edinburgh UK)
O
Ole‐Petter Riksfjord Hamnvik
(Department of Medicine Brigham and Women’s Hospital, Harvard Medical School Boston Massachusetts USA)
Article Details
Volume / Issue
Vol. 75, Issue 5
Published
October 01, 2025
Pages
376-386
ISSN
0007-9235
Publisher
Wiley
Authors (7)
A
Alison May Berner
Queen Mary University of London London UK
T
Tristan Michael MacKenzie
University of Edinburgh School of Divinity Edinburgh UK
S
Shirish Kulkarni
Edinburgh Cancer Center Edinburgh UK
C
Chin Chong
Waterside Gender Clinic Edinburgh UK
L
Loren Schechter
Gender Affirmation Surgery Rush University Medical Center Chicago Illinois USA
C
Caroline Michie
Edinburgh Cancer Center Edinburgh UK
O
Ole‐Petter Riksfjord Hamnvik
Department of Medicine Brigham and Women’s Hospital, Harvard Medical School Boston Massachusetts USA
Related Articles from this Journal
Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates
Xia Wu, Heather Landau et al.
May 2026
10.3322/caac.70092
Screening for colorectal cancer
May 2026
10.3322/caac.70087
Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”
May 2026
10.3322/caac.70093
Blood tests for colorectal cancer—Hype ahead of evidence?
Gloria D. Coronado, David A. Lieberman
May 2026
10.3322/caac.70088
Medullary thyroid carcinoma and <i>RET</i> molecular testing: A virtual tumor board on clinical decision‐making
Lucas Kallas‐Silva, Victor Alexandre dos Santos Valsecchi et al.
May 2026
10.3322/caac.70086